Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-05-009848
Filing Date
2005-03-31
Accepted
2005-03-31 17:08:34
Documents
7
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 v015409_10k.htm 10-K 1127399
2 v015409_ex14-1.htm EX-14.1 59662
3 v015409_ex21-1.htm EX-21.1 4022
4 v015409_ex31-1.htm EX-31.1 8920
5 v015409_ex31-2.htm EX-31.2 8939
6 v015409_ex32-1.htm EX-32.1 5402
7 v015409_ex32-2.htm EX-32.2 5280
  Complete submission text file 0001144204-05-009848.txt   1221819
Mailing Address 5511 CAPITAL CENTER DRIVE SUITE 224 RALEIGH NC 27606
Business Address 5511 CAPITAL CENTER DRIVE SUITE 224 RALEIGH NC 27606 919-852-4482
Grant Life Sciences, Inc. (Filer) CIK: 0001210336 (see all company filings)

EIN.: 820490737 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50133 | Film No.: 05721566
SIC: 2835 In Vitro & In Vivo Diagnostic Substances